Dupilumab improves patient-reported symptoms and health-related quality of life in children aged 6-11 years with severe atopic dermatitis.
Carsten FlohrAlan D IrvineMichael J CorkEric L SimpsonAndreas WollenbergMette DeleuranAmy PraestgaardRyan B ThomasAna B RossiPublished in: The British journal of dermatology (2023)